Target intelligence / Profile preview

Transmembrane protein 89 (TMEM89)

Target
TMEM89
Molecular classification
Transmembrane protein, Other
01

Overview

Transmembrane protein 89 (TMEM89) is a human protein encoded by the TMEM89 gene located on chromosome 3p21.31. The protein is 159 amino acids long, with two topological domains (extracellular and cytoplasmic) and a single transmembrane α-helix. TMEM89 is structurally rich in histidine, leucine, and tryptophan, and displays conserved regions among mammals but is uncharacterized functionally. It shows highest expression in the testis, with lower levels in several other tissues, and has predicted roles in protein–protein interactions, cell signaling, cytoskeletal organization, and membrane trafficking due to the presence of domains such as a predicted SH3-binding domain, N-myristylation site, and phosphorylation site. Clinically, TMEM89 has been proposed as a possible biomarker for upper tract urothelial carcinomas and may have modulatory roles in autism spectrum disorder severity and testicular germ cell tumor prognosis, but it is not currently considered a validated therapeutic target and has no known drug modulators.

Other names
TMEM89transmembrane protein 89
02

Biological functions

Unknown (uncharacterized)Potential role in protein-protein interactionsPotential involvement in membrane traffickingPossible role in signal transduction
03

Disease associations

Cancer (notably upregulated in upper tract urothelial carcinoma, potentially a biomarker)Autism spectrum disorder (modifier of severity)Testicular germ cell tumors (prognostic risk factor)
04

Biomarkers

Potential biomarker for upper tract urothelial carcinoma

Beyond the preview

Go deeper on Transmembrane protein 89 (TMEM89).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 89 (TMEM89).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call